RxDoctor Payments Data

Nicholas Abt, MD

Otolaryngology · Mashpee, MANPI 1942623566

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,447 of the $5,525 with a category attached, or 62.4%. It is spread thinly across 16 manufacturers, the largest accounting for just 18.6%. Reporting peaked in 2022 at $1,759 and has fallen 72.4% since, to $486 in 2025.

$5,525in general payments, 2019–2025

Across 69 payments — averaging $80.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Axogen$940
  • Medical Device Business Services, Inc.$809
  • Inspire Medical Systems, Inc.$703
  • Sanofi$537
  • Regeneron Healthcare Solutions, Inc.$466
  • plus $1K from 10 others

What the payments were for

  • Travel & lodging$97918%
  • Food & beverage$3,44762%
  • Education$1,09920%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,525 in reported general payments places this provider in the 85th percentile of 298 otolaryngology providers in Massachusetts.

See all otolaryngology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$282,642
Medicare patients
408
Services billed
5,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl124$2,903
Omeprazole89$1,023
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen87$690
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort11$591
Ipratropium Bromide20$522
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$411
Mupirocin35$364
Doxycycline Hyclate25$327
Methylprednisolone52$273
Calcitriol25$263
Pentoxifylline16$238
Nystatin15$197
Celecoxib12$178
Gabapentin15$108
Levofloxacin18$101

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mashpee

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →